Heme oxygenase-1, oxidation, inflammation, and atherosclerosis

Frontiers in Pharmacology

Volumn 3 JUL, Issue , 2012, Pages

  Araujo, Jesus A ^a   Zhang, Min ^a   Yin, Fen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Bilirubin; Carbon monoxide; Heme oxygenase; Inflammation; Iron; Oxidative stress

Indexed keywords

ADENOVIRUS VECTOR; BILIRUBIN; BILIVERDIN; CARBON MONOXIDE; DEFEROXAMINE; FERROUS ION; HEME OXYGENASE 1; HEME OXYGENASE 2; HEMIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTOPORPHYRIN COBALT; PROTOPORPHYRIN TIN; PROTOPORPHYRIN ZINC; TRANSCRIPTION FACTOR NRF2;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; AORTA ATHEROSCLEROSIS; AORTA INJURY; ARTERY INTIMA PROLIFERATION; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BRAIN MALARIA; CAROTID ATHEROSCLEROSIS; DENDRITIC CELL; ENZYME ACTIVITY; GENE; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; HO 1 GENE; HUMAN; IMMUNOMODULATION; INFLAMMATION; IRON KINETICS; LYMPHOCYTE; MACROPHAGE; MCP 1 GENE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; SMOOTH MUSCLE FIBER; TRANSCRIPTION INITIATION; VIRAL GENE DELIVERY SYSTEM;

EID: 84866176037     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00119     Document Type: Review

References (133)

1. Abraham, N. G., and Kappas,A. (2008). Pharmacological and clinical aspects of heme oxygenase. Pharmacol. Rev. 60, 79-127.
2. Amersi, F., Buelow, R., Kato, H., Ke, B., Coito, A. J., Shen, X. D., Zhao, D., Zaky, J., Melinek, J., Lassman, C. R., Kolls, J. K., Alam, J., Ritter, T., Volk, H. D., Farmer, D. G., Ghobrial, R. M., Busuttil, R. W., and Kupiec-Weglinski, J. W. (1999). Upregula-tion of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J. Clin. Invest. 104, 1631-1639.
3. Araujo, J. (2011). Particulate air pollution, systemic oxidative stress, inflammation, and atherosclerosis. Air Qual. Atmos. Health 4, 79-93.
4. Araujo, J., Ishikawa, K., and Lusis, A. J. (2002). " Heme Oxygenase and Atherosclerosis," in Heme Oxygenase: Biology and Medicine, ed. N. Abraham (New York: Kluwer Publisher), 269-278.
5. Araujo, J. A. (2012). Nrf2 and the promotion of atherosclerosis: lessons to be learned. Clin. Lipidol. 7, 123-116.
6. Araujo, J. A., Meng, L., Tward, A. D., Hancock, W. W., Zhai, Y., Lee, A., Ishikawa, K., Iyer, S., Buelow, R., Busuttil, R. W., Shih, D. M., Lusis, A. J., and Kupiec-Weglinski, J. W. (2003). Systemic rather than local heme oxygenase-1 overexpres-sion improves cardiac allograft outcomes in a new transgenic mouse. J. Immunol. 171, 1572-1580.
7. Balla, G., Jacob, H. S., Balla, J., Rosenberg, M., Nath, K., Apple, F., Eaton, J. W., and Vercellotti, G. M. (1992). Ferritin: a cytoprotective antioxi-dant strategem of endothelium. J. Biol. Chem. 267, 18148-18153.
8. Balla, G., Jacob, H. S., Eaton, J. W., Belcher, J. D., and Vercellotti, G. M. (1991). Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothe-lial injury. Arterioscler. Thromb. Vasc. Biol. 11, 1700-1711.
9. Balla, J., Jacob, H. S., Balla, G., Nath, K., Eaton, J. W., and Vercellotti, G. M. (1993). Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensiti-zation to oxidant damage. Proc. Natl. Acad. Sci. U.S.A. 90, 9285-9289.
10. Barajas, B., Che, N.,Yin, F., Rowshanrad, A.,Orozco,L.D., Gong,K.W.,Wang, X., Castellani, L. W., Reue, K., Lusis, A. J., andAraujo,J.A.(2011). NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipopro-teins and cholesterol transport that overshadow antioxidant protection. Arterioscler. Thromb. Vasc. Biol. 31, 58-66.
11. Baranano, D. E., Rao, M., Ferris, C. D., and Snyder, S. H. (2002). Biliverdin reductase: a major physiologic cyto-protectant. Proc. Natl. Acad. Sci. U.S.A. 99, 16093-16098.
12. Barry-Lane, P. A., Patterson, C., Van Der Merwe, M., Hu, Z., Holland, S. M., Yeh, E. T., and Runge, M. S. (2001). p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J. Clin. Invest. 108, 1513-1522.
13. Berberat, P. O., Katori, M., Kaczmarek, E., Anselmo, D., Lassman, C., Ke, B., Shen, X., Busuttil, R. W., Yamashita, K., Csizmadia, E., Tyagi, S., Otter-bein, L. E., Brouard, S., Tobiasch, E., Bach, F. H., Kupiec-Weglinski, J. W., and Soares, M. P. (2003). Heavy chain ferritin acts as an antiapop-totic gene that protects livers from ischemia reperfusion injury. FASEB J. 17, 1724-1726.
14. Bilban, M., Haschemi, A., Wegiel, B., Chin, B. Y., Wagner, O., and Otter-bein, L. E. (2008). Heme oxyge-nase and carbon monoxide initiate homeostatic signaling. J. Mol. Med. 86, 267-279.
15. Bobryshev, Y. V. (2005). Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur. Heart J. 26, 1700-1704.
16. Bobryshev, Y. V. (2010). Dendritic cells and their role in atherogenesis. Lab. Investig. 90, 970-984.
17. Bouhlel, M. A., Derudas, B., Rigamonti, E., Dievart, R., Brozek, J., Haulon, S., Zawadzki, C., Jude, B., Torpier, G., Marx, N., Staels, B., and Chinetti-Gbaguidi, G. (2007). PPAR gamma activationprimeshumanmonocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 6, 137-143.
18. Boyle, J. J., Harrington, H. A., Piper, E., Elderfield, K., Stark, J., Lan-dis, R. C., and Haskard, D. O. (2009). Coronary intraplaque hemorrhage evokes a novel atheroprotec-tive macrophage phenotype. Am. J. Pathol. 174, 1097-1108.
19. Boyle, J. J., Johns, M., Kampfer, T., Nguyen, A. T., Game, L., Schaer, D. J., Mason, J. C., and Haskard, D. O. (2012). Activating transcription factor 1 directs mhem atheropro-tective macrophages through coordinated iron handling and foam cell protection. Circ. Res. 110, 20-33.
20. Boyle, J. J., Johns, M., Lo, J., Chiodini, A., Ambrose,N., Evans,P. C., Mason, J. C., and Haskard, D. O. (2011). Heme induces heme oxygenase 1 via Nrf2 role in the homeostatic macrophage responsetointraplaque hemorrhage. Arterioscler. Thromb. Vasc. Biol. 31, U2685-U2826.
21. Brasen, J. H., Leppanen, O., Inkala, M., Heikura, T., Levin, M., Ahrens, F., Rutanen, J., Pietsch, H., Bergqvist, D., Levonen,A. L., Basu, S., Zeller, T., Kloppel, G., Laukkanen, M. O., and Yla-Herttuala, S. (2007). Extracellular superoxide dismutase accelerates endothelial recovery and inhibits in-stent restenosis in stented atherosclerotic Watanabe heritable hyper-lipidemic rabbit aorta. J. Am. Coll. Cardiol. 50, 2249-2253.
22. Brouard, S., Otterbein, L. E., Anrather, J., Tobiasch, E., Bach, F. H., Choi, A. M., and Soares, M. P. (2000). Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J. Exp. Med. 192, 1015-1026.
23. Burns, M. J., and Furie, M. B. (1998). Borrelia burgdorferi and interleukin-1 promote the transendothelial migration of monocytes in vitro by different mechanisms. Infect. Immun. 66, 4875-4883.
24. Callegari, A., Liu, Y., White, C. C., Chait, A., Gough, P., Raines, E. W., Cox, D., Kavanagh, T. J., and Rosen-feld, M. E. (2011). Gain and loss of function for glutathione synthesis: impact on advanced atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 31, 2473-2482.
25. Chauveau, C., Remy, S., Royer, P. J., Hill, M., Tanguy-Royer, S., Hubert, F. X., Tesson, L., Brion, R., Beriou, G., Gregoire, M., Josien, R., Cuturi, M. C., and Anegon, I. (2005). Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 106, 1694-1702.
26. Chen, Y. H., Chau, L. Y., Lin, M. W., Chen, L. C., Yo, M. H., Chen, J. W., and Lin, S. J. (2004). Heme oxygenase-1 gene promo-tor microsatellite polymorphism is associated with angiographic restenosis after coronary stenting. Eur. Heart J. 25, 39-47.
27. Chen, Y. H., Lin, S. J., Lin, M. W., Tsai, H. L., Kuo, S. S., Chen, J. W., Charng, M. J., Wu, T. C., Chen, L. C., Ding, Y. A., Pan, W. H., Jou, Y. S., and Chau,L.Y. (2002). Microsatellite polymorphism in promoterof heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2diabetic patients.Hum. Genet. 111, 1-8.
28. Cheng, C., Noordeloos, A. M., Jeney, V., Soares, M. P., Moll, F., Pasterkamp, G., Serruys, P. W., and Duckers, H. J. (2009). Heme oxygenase 1 determines atherosclerotic lesion progression into a vulnerable plaque. Circulation 119, 3017-3027.
29. Choi, A. M., and Alam, J. (1996). Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am. J. Respir. Cell Mol. Biol. 15, 9-19.
30. Coito, A. J., Buelow, R., Shen, X. D., Amersi, F., Moore, C., Volk, H. D., Busuttil, R. W., and Kupiec-Weglinski, J. W. (2002). Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury. Transplantation 74, 96-102.
31. Converso, D. P., Taille, C., Carreras, M. C., Jaitovich, A., Poderoso, J. J., and Boczkowski, J. (2006). HO-1 is located in liver mitochondria and modulates mitochondrialheme content and metabolism. FASEB J. 20, 1236-1238.
32. Duckers, H. J., Boehm, M., True, A. L., Yet, S. F., San, H., Park, J. L., Clinton Webb, R., Lee, M. E., Nabel, G. J., and Nabel, E. G. (2001). Heme oxygenase-1 protects against vascular constriction and proliferation. Nat. Med. 7, 693-698.
33. Durand, E., Al Haj Zen, A., Addad, F., Brasselet, C., Caligiuri, G., Vinchon,F.,Lemarchand,P.,Desnos,M., Bruneval, P., and Lafont, A. (2005). Adenovirus-mediated gene transfer of superoxide dismutase and cata-lase decreases restenosis after balloon angioplasty. J. Vasc. Res. 42, 255-265.
34. Durante, W. (2011). Protective role of heme oxygenase-1 against inflammation in atherosclerosis. Front. Biosci. 16, 2372-2388.
35. Exner, M., Schillinger, M., Minar, E., Mlekusch, W., Schlerka, G., Haumer, M., Mannhalter, C., and Wagner, O. (2001). Hemeoxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angio-plasty. J. Endovasc. Ther. 8, 433-440.
36. Fondevila, C., Shen, X. D., Tsuchiyashi, S., Yamashita, K., Csizmadia, E., Lassman, C., Busuttil, R. W., Kupiec-Weglinski, J. W., and Bach, F. H. (2004). Biliverdin therapy protects rat livers from ischemia and reperfusion injury. Hepatology 40, 1333-1341.
37. Freigang, S., Ampenberger, F., Spohn, G., Heer, S., Shamshiev, A. T., Kisielow, J., Hersberger, M., Yamamoto, M., Bachmann, M. F., and Kopf, M. (2011). Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis. Eur. J. Immunol. 41, 2040-2051.
38. Gleissner, C. A. (2012). Macrophage phenotype modulation by CXCL4 in atherosclerosis. Front. Physiol. 3:1. doi:10.3389/fphys.2012.00001
39. Gleissner, C. A., Shaked, I., Little, K. M., and Ley, K. (2010). CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages. J. Immunol. 184, 4810-4818.
40. Gong, K. W., Zhao, W., Li, N., Barajas, B., Kleinman, M., Sioutas, C., Hor-vath, S., Lusis, A. J., Nel, A., and Araujo, J. A. (2007). Air-pollutant chemicals and oxidized lipids exhibit genome-wide synergistic effects on endothelial cells. Genome Biol. 8, R149.
41. Hancock, W. W., Buelow, R., Sayegh, M. H., and Turka, L. A. (1998). Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat. Med. 4, 1392-1396.
42. Harrison, P. M., and Arosio, P. (1996). The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta 1275, 161-203.
43. Hartsfield, C. L. (2002). Cross talk between carbon monoxide and nitric oxide. Antioxid. Redox Signal. 4, 301-307.
44. Hayashi, S., Omata, Y., Sakamoto, H., Higashimoto, Y., Hara, T., Sagara, Y., and Noguchi, M. (2004).Characteri-zationof rat heme oxygenase-3 gene. Implication of processed pseudo-genes derived from heme oxygenase-2 gene. Gene 336, 241-250.
45. Hopkins, P. N., Wu, L. L., Hunt, S. C., James, B. C., Vincent, G. M., and Williams, R. R. (1996). Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 16, 250-255.
46. Huang, J., Tabbi-Anneni, I., Gunda, V., and Wang, L. (2010). Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G1211-G1221.
47. Ishii, T., Itoh, K., Ruiz, E., Leake, D. S., Unoki, H., Yamamoto, M., and Mann, G. E. (2004). Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ. Res. 94, 609-616.
48. Ishikawa, K., Navab, M., and Lusis, A. J. (2012). Vascultiis, atherosclerosis, and altered HDL composition in heme-oxygenase-1-knockout mice. Int. J. Hypertens. doi: 10.1155/2012/948203
49. Ishikawa, K., Sugawara, D., Goto, J., Watanabe,Y.,Kawamura,K.,Shiomi, M., Itabe, H., and Maruyama, Y. (2001a). Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation 104, 1831-1836.
50. Ishikawa, K., Sugawara, D., Wang, X., Suzuki, K., Itabe, H., Maruyama, Y., and Lusis, A. J. (2001b). Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. Circ. Res. 88, 506-512.
51. Jeney, V., Balla, J., Yachie, A., Varga, Z., Vercellotti, G. M., Eaton, J. W., and Balla, G. (2002). Pro-oxidant and cytotoxic effects of circulating heme. Blood 100, 879-887.
52. Juan, S. H., Lee, T. S., Tseng, K. W., Liou, J. Y., Shyue, S. K., Wu, K. K., and Chau, L. Y. (2001). Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104, 1519-1525.
53. Juckett, M. B., Balla, J., Balla, G., Jes-surun, J., Jacob, H. S., and Vercel-lotti, G. M. (1995). Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. Am. J. Pathol. 147, 782-789.
54. Kadir, F. H., and Moore, G. R. (1990). Haem binding to horse spleen ferritin. FEBS Lett. 276, 81-84.
55. Kadl, A., Meher, A. K., Sharma, P. R., Lee, M. Y., Doran, A. C., Johnstone, S. R., Elliott, M. R., Gruber, F., Han, J., Chen, W., Kensler,T., Ravichandran,K.S., Isak-son, B. E., Wamhoff, B. R., and Leitinger, N. (2010). Identification of a novel macrophage pheno-type that develops in response to atherogenic phospholipids via Nrf2. Circ. Res. 107, 737-746.
56. Kaneda, H., Ohno, M., Taguchi, J., Togo, M., Hashimoto, H., Ogasawara, K., Aizawa, T., Ishizaka, N., and Nagai, R. (2002). Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler. Thromb. Vasc. Biol. 22, 1680-1685.
57. Kapitulnik, J., and Maines,M. D. (2009). Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cyto-toxic bilirubin. Trends Pharmacol. Sci. 30, 129-137.
58. Kato, H., Amersi, F., Buelow, R., Melinek, J., Coito,A. J., Ke, B., Busut-til, R. W., and Kupiec-Weglinski, J. W. (2001). Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am. J. Transplant. 1, 121-128.
59. Kawashima, A., Oda, Y., Yachie, A., Koizumi, S., and Nakanishi, I. (2002). Heme oxygenase-1 deficiency: the first autopsy case. Hum. Pathol. 33, 125-130.
60. Ke, B., Shen, X. D., Melinek, J., Gao, F., Ritter, T., Volk, H. D., Busut-til, R. W., and Kupiec-Weglinski, J. W. (2001). Heme oxygenase-1 gene therapy: a novel immunomodula-toryapproach inliver allograft recipients? Transplant. Proc. 33, 581-582.
61. Ke, B. B., Shen, X. D., Melinek, J., Busut-til, R. W., and Kupiec-Weglinski, J. W. (2000). Heme oxygenase-1 gene therapyupregulatesTH2-dependent expression of protective molecules in liver allograft recipents: implications for novel immunomodulatory approach. Transplantation 69, S280.
62. Khoo, N. K., and Freeman, B. A. (2010) Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment. Curr. Opin. Pharmacol. 10, 179-184.
63. Kim, H. P., Wang, X., Galbiati, F., Ryter, S. W., and Choi, A. M. (2004). Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB J. 18, 1080-1089.
64. Krausgruber, T., Blazek, K., Smallie, T., Alzabin, S., Lockstone, H., Sahgal, N., Hussell, T., Feldmann, M., and Udalova,I.A.(2011). IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 12, 231-238.
65. Kruger, A. L., Peterson, S., Turkseven, S., Kaminski, P. M., Zhang, F. F., Quan, S., Wolin, M. S., and Abraham, N. G. (2005). D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation 111, 3126-3134.
66. Kruger, A. L., Peterson, S. J., Schwartz-man, M. L., Fusco, H., Mcclung, J. A., Weiss, M., Shenouda, S., Goodman, A. I., Goligorsky, M. S., Kappas, A., and Abraham, N. G. (2006). Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects. J. Pharmacol. Exp. Ther. 319, 1144-1152.
67. Lamb, N. J., Quinlan, G. J., Mumby, S., Evans, T. W., and Gutteridge, J. M. (1999). Haem oxygenase shows pro-oxidant activity in microsomal and cellular systems: implications for the release of low-molecular-mass iron. Biochem. J. 344(Pt 1), 153-158.
68. Laukkanen, M. O., Kivela, A., Rissa-nen, T., Rutanen, J., Karkkainen, M. K., Leppanen, O., Brasen, J. H., and Yla-Herttuala, S. (2002). Adenovirus-mediated extracellular superoxide dismutase gene therapy reduces neointima formation in balloon-denuded rabbit aorta. Circulation 106, 1999-2003.
69. Lee, T. S., Tsai, H. L., and Chau, L. Y. (2003). Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta(12,14)-prostaglandin J(2). J. Biol. Chem. 278, 19325-19330.
70. Lerner-Marmarosh, N., Shen, J., Torno, M. D., Kravets, A., Hu, Z., and Maines, M. D. (2005). Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity. Proc. Natl. Acad. Sci. U.S.A. 102, 7109-7114.
71. Levonen, A. L., Inkala, M., Heikura, T., Jauhiainen, S., Jyrkkanen, H. K., Kansanen, E., Maatta, K., Romppa-nen, E., Turunen, P., Rutanen, J., and Yla-Herttuala, S. (2007). Nrf2 gene transfer induces antioxidant enzymes and suppresses smooth muscle cell growth in vitro and reduces oxidative stress in rabbit aorta in vivo. Arterioscler. Thromb. Vasc. Biol. 27, 741-747.
72. Lewis, P., Stefanovic, N., Pete, J., Calkin, A. C., Giunti, S., Thallas-Bonke, V., Jandeleit-Dahm, K. A., Allen, T. J., Kola,I.,Cooper,M. E., andDe Haan, J. B. (2007). Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice. Circulation 115, 2178-2187.
73. Li, T., Tian, H., Zhao, Y., An, F., Zhang, L., Zhang, J., Peng, J., Zhang, Y., and Guo, Y. (2011). Heme oxygenase-1 inhibits progression and destabiliza-tion of vulnerable plaques in a rabbit model of atherosclerosis. Eur. J. Pharmacol. 672, 143-152.
74. Lin, Q., Weis, S., Yang, G., Weng, Y. H., Helston, R., Rish, K., Smith, A., Bordner, J., Polte, T., Gaunitz, F., and Dennery, P. A. (2007). Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J. Biol. Chem. 282, 20621-20633.
75. Lin, Q. S., Weis, S., Yang, G., Zhuang, T., Abate, A., and Dennery,P. A. (2008). Catalytic inactive heme oxygenase-1 protein regulates its own expression in oxidative stress. Free Radic. Biol. Med. 44, 847-855.
76. Liu, D., He, Z., Wu, L., and Fang, Y. (2012). Effects of induction/ inhibition of endogenous heme oxygenase-1 on lipid metabolism, endothelial function, and atherosclerosis in rabbits on a high fat diet. J. Pharmacol. Sci. 118, 14-24.
77. Liu, X. M., Chapman, G. B., Wang, H., and Durante, W. (2002). Adenovirus-mediated heme oxygenase-1 gene expression stimulates apoptosis in vascular smooth muscle cells. Circulation 105, 79-84.
78. Llodra, J., Angeli, V., Liu, J., Trogan, E., Fisher, E. A., and Randolph, G. J. (2004). Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl. Acad. Sci. U.S.A. 101, 11779-11784.
79. Lusis, A. J. (2000). Atherosclerosis. Nature 407, 233-241.
80. Maines, M. D. (1997). The heme oxy-genase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37, 517-554.
81. Manthey, H., and Zernecke, A. (2011). Dendritic cells in atherosclerosis: functions in immune regulation and beyond. Thromb. Haemost. 106.
82. Minamino, T., Christou, H., Hsieh, C. M., Liu,Y. X., Dhawan,V., Abraham, N. G., Perrella, M. A., Mitsialis, S. A.,and Kourembanas,S.(2001). Targeted expressionof heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc. Natl. Acad. Sci. U.S.A. 98, 8798-8803.
83. Morita, T. (2005). Heme oxy-genase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 25, 1786-1795.
84. Morita, T., Mitsialis, S. A., Koike, H., Liu, Y., and Kourembanas, S. (1997). Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J. Biol. Chem. 272, 32804-32809.
85. Morita, T., Perrella, M. A., Lee, M. E., and Kourembanas, S. (1995). Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc. Natl. Acad. Sci. U.S.A. 92, 1475-1479.
86. Nagy, E. K., Eaton, J. W., Jeney, V. R., Soares, M. P., Varga, Z., Galajda, Z. N., Szentmiklósi, J. Z., Méhes, G. B., Csonka, T. S., Smith, A., Vercellotti, G. M., Balla, G. R., and Balla, J. Z. (2010).Redcells,hemoglobin,heme, iron, and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 30, 1347-1353.
87. Neuzil, J., and Stocker, R. (1994). Free and albumin-bound biliru-bin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J. Biol. Chem. 269, 16712-16719.
88. Novotny, L., and Vitek, L. (2003). Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp. Biol. Med. 228, 568-571.
89. Ollinger, R., Bilban, M., Erat, A., Froio, A., Mcdaid, J., Tyagi, S., Csizma-dia, E., Graca-Souza, A. V., Liloia, A., Soares, M. P., Otterbein, L. E., Usheva, A., Yamashita, K., and Bach, F. H. (2005). Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 112, 1030-1039.
90. Ollinger, R., Yamashita, K., Bilban, M., Erat,A., Kogler,P.,Thomas,M., Csiz-madia, E., Usheva, A., Margreiter, R., and Bach, F. H. (2007). Biliru-bin and biliverdin treatment of atherosclerotic diseases. Cell Cycle 6, 39-43.
91. Orozco, L. D., Kapturczak, M. H., Bara-jas, B., Wang, X., Weinstein, M. M., Wong, J., Deshane, J., Bolisetty, S., Shaposhnik, Z., Shih, D. M., Agar-wal, A., Lusis, A. J., and Araujo, J. A. (2007). Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ. Res. 100, 1703-1711.
92. Otterbein, L. E., Bach, F. H., Alam, J., Soares, M., Tao Lu, H., Wysk, M., Davis, R. J., Flavell, R. A., and Choi, A. M. (2000). Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6, 422-428.
93. Otterbein, L. E., Zuckerbraun, B. S., Haga, M., Liu, F., Song, R., Usheva, A., Stachulak, C., Bodyak, N., Smith, R. N., Csizmadia, E., Tyagi, S., Aka-matsu, Y., Flavell, R. J., Billiar, T. R., Tzeng, E., Bach, F. H., Choi, A. M., and Soares, M. P. (2003). Carbon monoxide suppresses arte-riosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat. Med. 9, 183-190.
94. Pamplona, A., Ferreira, A., Balla, J., Jeney, V., Balla, G., Epiphanio, S., Chora, A., Rodrigues, C. D., Gre-goire, I. P., Cunha-Rodrigues, M., Portugal, S., Soares, M. P., and Mota, M. M. (2007). Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat. Med. 13, 703-710.
95. Park, J. G., Yoo, J. Y., Jeong, S. J., Choi, J. H., Lee, M. R., Lee, M. N., Hwa Lee, J., Kim, H. C., Jo, H., Yu, D. Y., Kang, S. W., Rhee, S. G., Lee, M. H., and Oh, G. T. (2011). Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice. Circ. Res. 109, 739-749.
96. Phelan, D., Winter, G. M., Rogers, W. J., Lam, J. C., and Denison, M. S. (1998). Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin. Arch. Biochem. Biophys. 357, 155-163.
97. Philippidis, P., Mason, J. C., Evans, B. J., Nadra, I., Taylor, K. M., Haskard, D. O., and Landis, R. C. (2004). Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis -Antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ. Res. 94, 119-126.
98. Pittock, S. T., Norby, S. M., Grande, J. P., Croatt, A. J., Bren, G. D., Badley, A. D., Caplice, N. M., Griffin, M. D., and Nath,K.A.(2005).MCP-1isup-regulated in unstressed and stressed HO-1 knockout mice: pathophys-iologic correlates. Kidney Int. 68, 611-622.
99. Poss, K. D., and Tonegawa, S. (1997). Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. U.S.A. 94, 10919-10924.
100. Romanoski, C. E., Che, N., Yin, F., Mai, N., Pouldar, D., Civelek, M., Pan, C., Lee, S., Vakili, L., Yang, W. P., Kayne, P., Mungrue, I. N., Araujo, J. A., Berliner, J. A., and Lusis, A. J. (2011). Network for activation of human endothelial cells by oxidized phospholipids. Circ. Res. 109, E27-U52.
101. Ryter, S. W., and Tyrrell, R. M. (2000). The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro-and antioxidant properties. Free Radic. Biol. Med. 28, 289-309.
102. Sacerdoti, D., Colombrita, C., Ghattas, M. H., Ismaeil, E. F., Scapagnini, G., Bolognesi, M., Volti,G. L., and Abra-ham,N.G.(2005). Heme oxygenase-1 transduction in endothelial cells causes downregulation of monocyte chemoattractant protein-1 and of genes involved in inflammation and growth. Cell. Mol. Biol. 51, 363-370.
103. Sachais, B. S., Turrentine, T., Mckenna, J. M. D., Rux, A. H., Rader, D., and Kowalska, M. A. (2007). Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57BI/6 and apoE(-/-) mice. Thromb. Haemost. 98, 1108-1113.
104. Sarady, J. K., Otterbein, S. L., Liu, F., Otterbein, L. E., and Choi, A. M. (2002). Carbon monoxide modulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages. Am. J. Respir. Cell Mol. Biol. 27, 739-745.
105. Schillinger, M., Exner, M., Mlekusch, W., Domanovits, H., Huber, K., Mannhalter, C., Wagner, O., and Minar, E. (2002). Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm. Thromb. Res. 106, 131-136.
106. Schwertner, H. A. (1998). Association of smoking and low serum bilirubin antioxidant concentrations. Atherosclerosis 136, 383-387.
107. Schwertner, H. A., Jackson, W. G., and Tolan, G. (1994). Association of low serum concentration of biliru-bin with increased risk of coronary artery disease. Clin. Chem. 40, 18-23.
108. Schwertner, H. A., and Vitek, L. (2008). Gilbert syndrome, UGT1A1-28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 198, 1-11.
109. Sinal, C. J., and Bend, J. R. (1997). Aryl hydrocarbon receptor-dependent induction of cyp1a1 by bilirubin in mouse hepatoma hepa 1c1c7 cells. Mol. Pharmacol. 52, 590-599.
110. Singleton, J. W., and Laster, L. (1965). Biliverdin reductase of guinea pig liver. J. Biol. Chem. 240, 4780-4789.
111. Siow, R. C., Sato, H., and Mann, G. E. (1999). Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc. Res. 41, 385-394.
112. Soares, M. P., and Bach, F. H. (2009). Heme oxygenase-1: from biology to therapeutic potential. Trends. Mol. Med. 15, 50-58.
113. Soares, M. P., Lin, Y., Anrather, J., Csizmadia, E., Takigami, K., Sato, K., Grey, S.T., Colvin, R. B., Choi, A. M., Poss, K. D., and Bach, F. H. (1998). Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat. Med. 4, 1073-1077.
114. Sriram, V., and Patterson, C. (2001). Cell cycle in vasculoproliferative diseases: potential interventions and routes of delivery. Circulation 103, 2414-2419.
115. Stocker, R., and Keaney, J. F. Jr. (2004). Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84, 1381-1478.
116. Stocker, R., Yamamoto, Y., Mcdon-agh, A. F., Glazer, A. N., and Ames, B. N. (1987). Bilirubin is an antioxidant of possible physiological importance. Science 235, 1043-1046.
117. Sussan, T. E., Jun, J., Thimmulappa, R., Bedja, D., Antero, M., Gabrielson, K. L., Polotsky, V. Y., and Biswal, S. (2008). Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice. PLoS One 3, e3791. doi:10.1371/journal.pone.0003791
118. Taha, H., Skrzypek, K., Guevara, I., Nigisch, A., Mustafa, S., Grochot-Przeczek, A., Ferdek, P., Was, H., Kotlinowski, J., Kozakowska, M., Balcerczyk, A., Muchova, L., Vitek, L., Weigel, G., Dulak, J., and Jozkowicz, A. (2010). Role of heme oxygenase-1 in human endothe-lial cells: lesson from the promoter allelic variants. Arterioscler. Thromb. Vasc. Biol. 30, 1634-1641.
119. Tsuchihashi, S., Livhits, M., Zhai, Y., Busuttil, R. W., Araujo, J. A., and Kupiec-Weglinski, J. W. (2006). Basal rather than induced heme oxygenase-1 levels are crucial in the antioxidant cytoprotection. J. Immunol. 177, 4749-4757.
120. Tulis, D. A., Durante, W., Liu, X., Evans, A. J., Peyton, K. J., and Schafer, A. I. (2001). Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation 104, 2710-2715.
121. Wang, L. J., Lee,T. S., Lee, F. Y., Pai,R. C., and Chau,L.Y.(1998). Expression of heme oxygenase-1 in atherosclerotic lesions. Am. J. Pathol. 152, 711-720.
122. Wang, X. M., Kim, H. P., Nakahira, K., Ryter, S. W., and Choi, A. M. (2009). The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J. Immunol. 182, 3809-3818.
123. Weis, N., Weigert, A., Von Knethen, A., and Brune, B. (2009). Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. Mol. Biol. Cell 20, 1280-1288.
124. Wilson,H.M.(2010).Macrophageshet-erogeneity in atherosclerosis -implications for therapy. J. Cell. Mol. Med. 14, 2055-2065.
125. Wu, D., Nishimura, N., Kuo, V., Fiehn, O., Shahbaz, S., Van Winkle, L., Matsumura, F., and Vogel, C. F. (2011). Activation of aryl hydrocarbon receptor induces vascular inflammation and promotes athero-sclerosisinapolipoprotein E-/-mice. Arterioscler. Thromb. Vasc. Biol. 31, 1260-1267.
126. Wu,T.W.,Fung,K.P.,Wu,J.,Yang,C.C., and Weisel, R. D. (1996). Antioxida-tion of human low density lipopro-tein by unconjugated and conjugated bilirubins. Biochem. Pharmacol. 51, 859-862.
127. Wuttge, D. M., Eriksson, P., Sirsjö, A., Hansson, G. K., and Stemme, S. (2001). Expression of interleukin-15 in mouse and human atherosclerotic lesions. Am. J. Pathol. 159, 417.
128. Yachie, A., Niida, Y., Wada, T., Igarashi, N., Kaneda, H., Toma, T., Ohta, K., Kasahara,Y.,and Koizumi,S.(1999). Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency.J. Clin. Invest. 103, 129-135.
129. Yamada, N., Yamaya, M., Okinaga, S., Nakayama, K., Sekizawa, K., Shiba-hara, S., and Sasaki, H. (2000). Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am. J. Hum. Genet. 66, 187-195.
130. Yamashita, K., Mcdaid, J., Ollinger, R., Tsui, T. Y., Berberat, P. O., Usheva, A., Csizmadia, E., Smith, R. N., Soares, M. P., and Bach, F. H. (2004). Biliverdin,a natural productof heme catabolism, induces tolerance to cardiac allografts. FASEB J.18, 765-767.
131. Yan, Z. Q., and Hansson, G. K. (2007). Innate immunity, macrophage activation, and atherosclerosis. Immunol. Rev. 219, 187-203.
132. Yet, S. F., Layne, M. D., Liu, X., Chen, Y. H., Ith, B., Sibinga, N. E., and Perrella, M. A. (2003). Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J. 17, 1759-1761.
133. Yilmaz, A., Lochno, M., Traeg, F., Cicha, I., Reiss, C., Stumpf, C., Raaz, D., Anger, T., Amann, K., Probst, T., Ludwig, J., Daniel, W. G., and Garlichs, C. D. (2004). Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis 176, 101-110.